๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Effect of Emergency Urinary Drainage on Subsequent PCNL Outcomes in Obstructive Urosepsis

RecruitingNAAges 18 Years - anyAllBeni-Suef University
NCT07826325 on ClinicalTrials.gov โ†—
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Obstructive urolithiasis complicated by urosepsis is a life-threatening medical emergency requiring urgent urinary tract decompression. Emergency drainage is typically achieved by either retrograde ureteral stent (RUS) insertion or percutaneous nephrostomy (PCN). Following clinical stabilization and resolution of infection, percutaneous nephrolithotomy (PCNL) is commonly performed as definitive stone treatment. This prospective comparative study aims to evaluate and compare the outcomes of subsequent PCNL between patients who underwent emergency drainage via retrograde ureteral stent and those who underwent percutaneous nephrostomy. The main outcomes to be compared include stone-free rates, operative time, blood loss, postoperative complications, length of hospital stay, and the need for auxiliary procedures.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Age 18 years or older. * Presence of renal or proximal ureteral stones. * Presentation with urosepsis secondary to obstructive urolithiasis. * Emergency urinary decompression performed by either retrograde ureteral stent (Double-J stent) or percutaneous nephrostomy (PCN). * Patients scheduled for definitive stone management via percutaneous nephrolithotomy (PCNL) after clinical stabilization and infection resolution. * Written informed consent obtained prior to enrollment. Exclusion Criteria: * Congenital renal anomalies (e.g., horseshoe kidney, ectopic kidney). * Pregnancy. * Uncorrectable coagulopathy or bleeding disorders. * Active, uncontrolled urinary tract infection at the time of definitive PCNL. * Severe cardiopulmonary comorbidities rendering the patient unfit for surgery or general anesthesia. * Patients managed definitively by other modalities (e.g., ureteroscopy or ESWL alone).
๐Ÿ’Š

What it tests

  • Retrograde Ureteral Stenting followed by PCNL
  • Percutaneous Nephrostomy followed by PCNL
๐Ÿ“

Where

1 site
Faculty of Medicine, Beni-Suef University
Banฤซ Suwayf, Egypt
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy